268 related articles for article (PubMed ID: 32609951)
1. Pantoprazole, a proton-pump inhibitor, impairs human sperm motility and capacitation in vitro.
Escoffier J; Arnaud B; Kaba M; Hograindleur JP; Le Blévec E; Martinez G; Stévant I; Ray PF; Arnoult C; Nef S
Andrology; 2020 Nov; 8(6):1795-1804. PubMed ID: 32609951
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole.
Abed MN; Alassaf FA; Jasim MHM; Alfahad M; Qazzaz ME
Pharmacology; 2020; 105(11-12):645-651. PubMed ID: 32289807
[TBL] [Abstract][Full Text] [Related]
3. Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study.
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Eur J Intern Med; 2019 Jan; 59():65-69. PubMed ID: 30154038
[TBL] [Abstract][Full Text] [Related]
4. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
Li XQ; Andersson TB; Ahlström M; Weidolf L
Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
[TBL] [Abstract][Full Text] [Related]
5. Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software.
Akter S; Hassan MR; Shahriar M; Akter N; Abbas MG; Bhuiyan MA
Alzheimers Res Ther; 2015 Dec; 7():79. PubMed ID: 26714488
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
Welage LS; Berardi RR
J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
[TBL] [Abstract][Full Text] [Related]
7. Veratridine-sensitive Na
Candenas L; Pinto FM; Cejudo-Román A; González-Ravina C; Fernández-Sánchez M; Pérez-Hernández N; Irazusta J; Subirán N
Life Sci; 2018 Mar; 196():48-55. PubMed ID: 29307525
[TBL] [Abstract][Full Text] [Related]
8. Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women.
Terranova C; Petrella C; Improta G; Severini C; Signore F; Damiani P; Plotti F; Scarpignato C; Angioli R
Eur J Pharm Sci; 2014 Feb; 52():125-31. PubMed ID: 24215738
[TBL] [Abstract][Full Text] [Related]
9. Effect of human tubal fluid medium and hyperactivation inducers on stallion sperm capacitation and hyperactivation.
Arroyo-Salvo C; Sanhueza F; Fuentes F; Treulén F; Arias ME; Cabrera P; Silva M; Felmer R
Reprod Domest Anim; 2019 Feb; 54(2):184-194. PubMed ID: 30179285
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lysosomal enzyme activities by proton pump inhibitors.
Liu W; Baker SS; Trinidad J; Burlingame AL; Baker RD; Forte JG; Virtuoso LP; Egilmez NK; Zhu L
J Gastroenterol; 2013 Dec; 48(12):1343-52. PubMed ID: 23478938
[TBL] [Abstract][Full Text] [Related]
11. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
Caro JJ; Salas M; Ward A
Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of esomeprazole 40 mg, rabeprazole 20 mg, lansoprazole 30 mg, and pantoprazole 40 mg on intragastrıc pH in extensive metabolizer patients with gastroesophageal reflux disease.
Çelebi A; Aydın D; Kocaman O; Konduk BT; Şentürk Ö; Hülagü S
Turk J Gastroenterol; 2016 Sep; 27(5):408-414. PubMed ID: 27782887
[TBL] [Abstract][Full Text] [Related]
13. Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
Leonard CE; Bilker WB; Brensinger CM; Flockhart DA; Freeman CP; Kasner SE; Kimmel SE; Hennessy S
Stroke; 2015 Mar; 46(3):722-31. PubMed ID: 25657176
[TBL] [Abstract][Full Text] [Related]
14. Semi-automatized segmentation method using image-based flow cytometry to study sperm physiology: the case of capacitation-induced tyrosine phosphorylation.
Matamoros-Volante A; Moreno-Irusta A; Torres-Rodriguez P; Giojalas L; Gervasi MG; Visconti PE; Treviño CL
Mol Hum Reprod; 2018 Feb; 24(2):64-73. PubMed ID: 29186618
[TBL] [Abstract][Full Text] [Related]
15. Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients.
Pilotto A; Franceschi M; Leandro G; Scarcelli C; D'Ambrosio LP; Paris F; Annese V; Seripa D; Andriulli A; Di Mario F
World J Gastroenterol; 2007 Sep; 13(33):4467-72. PubMed ID: 17724802
[TBL] [Abstract][Full Text] [Related]
16. Exposure to ethanol during capacitation impairs the fertilizing ability of human spermatozoa in vitro.
Salonen I
Int J Androl; 1986 Aug; 9(4):259-70. PubMed ID: 3804467
[TBL] [Abstract][Full Text] [Related]
17. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
Clark DW; Strandell J
Eur J Clin Pharmacol; 2006 Jun; 62(6):473-9. PubMed ID: 16758264
[TBL] [Abstract][Full Text] [Related]
18. Extracellular cAMP activates molecular signalling pathways associated with sperm capacitation in bovines.
Alonso CAI; Osycka-Salut CE; Castellano L; Cesari A; Di Siervi N; Mutto A; Johannisson A; Morrell JM; Davio C; Perez-Martinez S
Mol Hum Reprod; 2017 Aug; 23(8):521-534. PubMed ID: 28521061
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole.
Gouraud A; Vochelle V; Descotes J; Vial T
Clin Drug Investig; 2010; 30(8):559-63. PubMed ID: 20586518
[TBL] [Abstract][Full Text] [Related]
20. Association Between Proton Pump Inhibitors and Microscopic Colitis.
Law EH; Badowski M; Hung YT; Weems K; Sanchez A; Lee TA
Ann Pharmacother; 2017 Mar; 51(3):253-263. PubMed ID: 27733667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
